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Abstract 
Cardiovascular diseases (CVDs) is a number one cause of death globally. WHO estimated that CVD is a cause of 
17.9 million deaths (or 31% of all global deaths) in 2016. It may seem surprising, CVDs can be easily prevented 
by altering lifestyle to avoid risk factors. The only requirement needed is to know your risk prior. Thai CV Risk 
score is a trustworthy tool to forecast risk of having cardiovascular event in the future for Thais. This study is an 
external validation of the Thai CV risk score. We aim to answer two key questions. Firstly, Can Thai CV Risk score 
developed using dataset of people from central and north western parts of Thailand is applicable to people 
from other parts of the country? Secondly, Can Thai CV Risk score developed for general public works for 
hospital’s patients who tend to have higher risk? We answer these two questions using a dataset of 1,025 
patients (319 males, 35-70 years old) from Lansaka Hospital in the southern Thailand. In brief, we find that the 
Thai CV risk score works for southern Thais population including patients in the hospital. It generally works well 
for low CV risk group. However, the score tends to overestimate moderate and high risks. Fortunately, this poses 
no serious concern for general public as it only makes people be more careful about their lifestyle. The doctor 
should be careful when using the score with other factors to make treatment decision. 
 
Introduction 
Cardiovascular diseases (CVDs) are the number one cause of death globally. In 2016, WHO estimated 
that 17.9 million people died from CVDs (or 31% of all global deaths). The deaths from CVDs are from individual 
or combined effects of high blood pressure, serum cholesterol, smoking, high blood glucose and high body mass 
index as shown in figure 1 [1]. Most CVDs can be prevented by modifying lifestyle to avoid behavioral risk factors 
or by preventive medical treatment. Therefore, it is essential to have a model that can predict cardiovascular 
(CV) risk of each individual. The world-first CV risk model, Framingham Risk Score, was developed based on findings 
from Framingham Heart Study [2].  
 
 
Figure 1: The deaths from CVDs in people aged >30 years attributable to the individual or combined effects of 
risk factors (high blood pressure, serum cholesterol, smoking, high blood glucose and high body mass index) by 
region and sex (A) and age group (B) from 1980 to 2010 
 
In Thailand, Thai CV Risk Score [3] was developed based on findings from The Electricity Generating 
Authority of Thailand (EGAT) study [4], shown in the Figure 2. The model was derived from the 1st EGAT cohort 
comprising survey and blood sample from 3,499 EGAT’s employees in Bangkok area in year 1985. The model was 
later on adjusted and validated using 2nd and 3rd EGAT cohorts comprising 2,999 and 2,584 samples from north 
western and central areas of Thailand respectively. 
 
Figure 2:  Electricity Generating Authority of Thailand (EGAT) Study 
 This work is an external validation of Thai CV risk score aiming to address three issues with cardiovascular 
diseases as follows. Firstly, the current Thai CV Risk Score was developed using cohort of people from central and 
north western parts of Thailand. The question is how well the score predicts the CV risk for people from other 
parts of the country? Secondly, CV risk is currently being used as a guideline to prescribe drugs in statins group for 
patients in hospitals. A question remains unanswered that how well the score developed for general public works 
for hospital’s patients who typically have higher risk.  
Finally, in the age of information, it is quite convenient to gather a large set of patients’ medical records, 
such as records from a hospital database. Medical community in UK exploits big data by using a dataset of 
roughly 10 million people in the development of their recent CV Risk Score, QRISK3 [5]. However, characteristics 
of this large dataset [8] are in many ways different from traditional cohort. Therefore, different methods to use 
the big data in medical research need to be studied and developed. This work is considered our first step in an 
attempt to use big data in the development of CV Risk Score in Thailand. 
 
 
Methods 
 
Figure 3: Methodology used in this study 
  
This work studied the use of the Thai CV Risk Score on patients at Lansaka hospital. Figure 3 illustrates 
methodology used in this study. The dataset contains records of 1,025 patients (319 males, 35-70 years old) with 
no cardiovascular event prior to 2008. We calculated 10-years cardiovascular risk using the following factors – 
sex, age, smoke, diabetes, systolic blood pressure, LHL and HDL -- of all patients in 2008 and observed their 
actual cardiovascular events from 2008 - 2017. In this study, target cardiovascular events are defined as a 
composite of fatal and non-fatal myocardial infarction or stroke as shown in the Table 1. 
 
 
 
 
 
Table 1: Cardiovascular Events 
 
 
Results 
Table 2 presents validation outcome of Thai CV risk score. The risk score indicates chances of having 
cardiovascular events in 10-year time. The score below 0.1, between 0.1 and 0.2, and more than 0.2 are 
interpreted as low, moderate, and high risks respectively. Therefore, we grouped Lansaka’s patients into 3 groups 
based on their predicted risk level and calculate actual risk for each group from cardiovascular events found 
between 2008 and 2017. In low risk group, on average, the risk score slightly underestimated the actual risk by 
0.0068. However, in both moderate and high-risk groups, the score, on average, overestimated the actual risk by 
0.037 and 0.088 respectively. 
 
Table 2: The validation outcome of Thai CV risk score 
 
 
Conclusion 
In brief, Thai CV risk score works for southern Thais population including patients in the hospital. It 
generally works well for low CV risk group. However, the score tends to overestimate moderate and high risks and 
the error goes up as the risk increases. Fortunately, this poses no serious concern for general public as it only 
makes people be more careful about their lifestyle. The doctor should be careful when using the score with other 
factors to make treatment decision. 
  
Limitations 
The data used in this study are from Lansaka hospital’s patient records. Due to several factors, such as 
migration, the 10-years dataset, from 2008 – 2017, might be incomplete. For example, if the patient moved to 
another city after 2008 and having cardiovascular event later on, the Lansaka’s dataset will indicate that this 
patient never have any CVD events, which is inaccurate. This is a type I censoring that leads to right censoring 
condition [7]. Patients who stay with Lansaka hospital for the entire 10-years period but have incomplete 
information for assessing CV risk are also excluded from our study. We make it our future work to resolve all of 
these limitations. 
 
Future Work 
A set of risk factors used in the current Thai CV risk score is similar to the original Framingham risk score 
[2]. However, the more recent CV risk score, such as QRISK3 [5], uses more extensive set of factors. Our research 
team aims to extend the current Thai CV risk score to includes additional factors that can help improve the 
assessment of the CV risk for all Thai. 
The data required to calculate the 10-year risk score are available for a small fraction of patients at 
Lansaka hospital. It is mainly due to missing cholesterol values, which is understandable since the blood draw is 
required to acquire this data. In this case, the waist to height ratio is used in place of cholesterol to assess CV 
risk. We are exploring a non-invasive approach to obtain these missing values and currently looking into using 
deep learning on retinal fundus images [6] to infer the missing information. 
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